Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Takahara N, Nakai Y, Isayama H, Sasaki T, Saito K, Noguchi K, Suzuki T, Nakamura T, Sato T, Ishigaki K, Hakuta R, Takeda T, Uchino R, Mizuno S, Kogure H, Tada M, Koike K. CA19-9 kinetics during systemic chemotherapy in patients with advanced or recurrent biliary tract cancer. Cancer Chemother Pharmacol 2017;80:1105-12. [PMID: 29038848 DOI: 10.1007/s00280-017-3456-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2017] [Accepted: 10/10/2017] [Indexed: 10/18/2022]

For:	Takahara N, Nakai Y, Isayama H, Sasaki T, Saito K, Noguchi K, Suzuki T, Nakamura T, Sato T, Ishigaki K, Hakuta R, Takeda T, Uchino R, Mizuno S, Kogure H, Tada M, Koike K. CA19-9 kinetics during systemic chemotherapy in patients with advanced or recurrent biliary tract cancer. Cancer Chemother Pharmacol 2017;80:1105-12. [PMID: 29038848 DOI: 10.1007/s00280-017-3456-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2017] [Accepted: 10/10/2017] [Indexed: 10/18/2022]

Number

Cited by Other Article(s)

Pawaskar R, Huang KZ, Pham H, Nagrial A, Wong M, O’Neill S, Pleass H, Yuen L, Lam VWT, Richardson A, Pang T, Nahm CB. Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma. Cancers (Basel) 2024;16:698. [PMID: 38398089 PMCID: PMC10886549 DOI: 10.3390/cancers16040698] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2024] [Revised: 02/03/2024] [Accepted: 02/05/2024] [Indexed: 02/25/2024] Open

Affiliation(s)

Rishaan Pawaskar Department of Upper GI Surgery, Westmead Hospital, Sydney, NSW 2145, Australia; (R.P.); (H.P.); (H.P.); (L.Y.); (V.W.T.L.); (A.R.); (T.P.)
Kevin Zhang Huang Westmead Hospital, Sydney, NSW 2145, Australia;
Helen Pham Department of Upper GI Surgery, Westmead Hospital, Sydney, NSW 2145, Australia; (R.P.); (H.P.); (H.P.); (L.Y.); (V.W.T.L.); (A.R.); (T.P.) Westmead Hospital, Sydney, NSW 2145, Australia; Surgical Innovations Unit, Westmead Hospital, Sydney, NSW 2145, Australia
Adnan Nagrial Westmead Clinical School, Faculty of Medicine and Health Sciences, The University of Sydney, Sydney, NSW 2006, Australia; (A.N.); (M.W.) Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, NSW 2145, Australia;
Mark Wong Westmead Clinical School, Faculty of Medicine and Health Sciences, The University of Sydney, Sydney, NSW 2006, Australia; (A.N.); (M.W.) Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, NSW 2145, Australia;
Siobhan O’Neill Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, NSW 2145, Australia;
Henry Pleass Department of Upper GI Surgery, Westmead Hospital, Sydney, NSW 2145, Australia; (R.P.); (H.P.); (H.P.); (L.Y.); (V.W.T.L.); (A.R.); (T.P.) Westmead Hospital, Sydney, NSW 2145, Australia; Surgical Innovations Unit, Westmead Hospital, Sydney, NSW 2145, Australia Westmead Clinical School, Faculty of Medicine and Health Sciences, The University of Sydney, Sydney, NSW 2006, Australia; (A.N.); (M.W.)
Lawrence Yuen Department of Upper GI Surgery, Westmead Hospital, Sydney, NSW 2145, Australia; (R.P.); (H.P.); (H.P.); (L.Y.); (V.W.T.L.); (A.R.); (T.P.) Westmead Hospital, Sydney, NSW 2145, Australia; Surgical Innovations Unit, Westmead Hospital, Sydney, NSW 2145, Australia Westmead Clinical School, Faculty of Medicine and Health Sciences, The University of Sydney, Sydney, NSW 2006, Australia; (A.N.); (M.W.)
Vincent W. T. Lam Department of Upper GI Surgery, Westmead Hospital, Sydney, NSW 2145, Australia; (R.P.); (H.P.); (H.P.); (L.Y.); (V.W.T.L.); (A.R.); (T.P.) Westmead Hospital, Sydney, NSW 2145, Australia; Surgical Innovations Unit, Westmead Hospital, Sydney, NSW 2145, Australia Westmead Clinical School, Faculty of Medicine and Health Sciences, The University of Sydney, Sydney, NSW 2006, Australia; (A.N.); (M.W.) Macquarie University Medical School, Macquarie University, Sydney, NSW 2145, Australia
Arthur Richardson Department of Upper GI Surgery, Westmead Hospital, Sydney, NSW 2145, Australia; (R.P.); (H.P.); (H.P.); (L.Y.); (V.W.T.L.); (A.R.); (T.P.) Westmead Hospital, Sydney, NSW 2145, Australia; Surgical Innovations Unit, Westmead Hospital, Sydney, NSW 2145, Australia
Tony Pang Department of Upper GI Surgery, Westmead Hospital, Sydney, NSW 2145, Australia; (R.P.); (H.P.); (H.P.); (L.Y.); (V.W.T.L.); (A.R.); (T.P.) Westmead Hospital, Sydney, NSW 2145, Australia; Surgical Innovations Unit, Westmead Hospital, Sydney, NSW 2145, Australia Westmead Clinical School, Faculty of Medicine and Health Sciences, The University of Sydney, Sydney, NSW 2006, Australia; (A.N.); (M.W.)
Christopher B. Nahm Department of Upper GI Surgery, Westmead Hospital, Sydney, NSW 2145, Australia; (R.P.); (H.P.); (H.P.); (L.Y.); (V.W.T.L.); (A.R.); (T.P.) Westmead Hospital, Sydney, NSW 2145, Australia; Surgical Innovations Unit, Westmead Hospital, Sydney, NSW 2145, Australia Westmead Clinical School, Faculty of Medicine and Health Sciences, The University of Sydney, Sydney, NSW 2006, Australia; (A.N.); (M.W.)

Collapse

Zheng K, Fu S, Leng B, Cui Y, Yang R, Cao G, Xu L, Li WQ, Li Y, Zhu X, Gao S, Liu P, Wang X. Signal enhancement ratio of CE-MRI: a potential biomarker of survival after hepatic arterial infusion chemotherapy in biliary tract cancers. Insights Imaging 2022;13:46. [PMID: 35286496 PMCID: PMC8921414 DOI: 10.1186/s13244-022-01188-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2021] [Accepted: 02/15/2022] [Indexed: 11/10/2022] Open